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Head/Director's Message 
David H. Zeman, DVM, PhD                       
 
High Containment Facility Needs of the ADRDL:  an update 
 
 As your Director of the SD Animal Disease Research 
and Diagnostic Laboratory (ADRDL), I have spoken to you 
in recent years about significant national and international 
trends that are impacting the way state animal health 
laboratories conduct business.  A variety of rising risk factors 
have increased the likelihood that state animal health 
laboratories will be significantly involved with animal 
disease outbreaks of high consequence, many of which are 
also human diseases. Some of these outbreaks may be 
accidental introductions of dangerous diseases into our 
service region, while others may be malicious introductions 
of foreign or manipulated pathogens.  The following rising 
risk factors and synergistic opportunities seem to make this 
the ideal time to seriously assess our situation: 
• Rising Risks due to Globalization of Animal 
Agriculture 
• Rising Risks due to Agroterrorism 
• Rising Risks due to Changing Societal Expectations 
o The environment and EPA regulations 
o Public/Community health and agricultural 
hazard control 
o Employee health hazards 
• Synergism with the VSD, ABS College and SDSU 
Research Programs 
• Synergism with State and Local High-Technology 
Economic Development  
• Synergism with Federal/State Diagnostic Networks 
(NAHLN, FERN, LRN) 
 
 In response to these trends, many state animal health 
laboratories have already built high containment facilities 
(BSL3) to handle pathogens of high consequence and of 
zoonotic concern.  Currently the ADRDL has no high 
containment diagnostic or research space.  A stakeholder 
committee has been formed by animal industry stakeholders 
to study and find solutions to this issue for South Dakota.  
Co-chairs of the committee are Christine Hamilton 
(Christianson Land and Cattle Company) and Dr. Dan 
Farrington (retired DVM industrial researcher).   They will 
work with key representatives of all friends of animal health 
in the state, to keep the ADRDL on the cutting edge of the 
ever-changing disciplines of diagnostic medicine and disease 
research.    
 
 
Diagnostic News - SDSU ADRDL 
 
Classical Swine Fever 
Surveillance (Hog Cholera) at 
the SDSU ADRDL: 
 
 The ADRDL has recently obtained a $75,000 
cooperative agreement grant from the USDA to conduct 
Classical Swine Fever (CSF) surveillance.  This disease, also 
known as Hog Cholera, is of high interest to the US swine 
industry.  The program is coordinated by the National Animal 
Health Lab Network (NAHLN).  ADRDL diagnosticians 
have been asked to test tissues from as many sick or dead 
pigs as possible, as they are submitted to the diagnostic 
laboratory for other routine disease investigations.  There will 
be no charge to our clients for this passive surveillance 
activity. 
 To encourage testing activity, practitioners will receive 
a financial reward for their efforts.  For any routine disease 
investigation a $50 credit per pig (up to 3 pigs per case; 
cannot exceed maximum bill for the case) can be applied to 
that diagnostic bill if appropriate specimens for CSF testing 
are included with your submission.   Appropriate specimens 
to qualify for the credit are: 
• Any age sick or dead pig from any of our clients 
(not restricted to SD clients) 
• Must submit dead pigs with tonsils or collect and 
submit a fresh tonsil during an on farm necropsy 
 
Animal Health Matters 
 This is a tremendous opportunity to participate in an 
important surveillance activity and receive free diagnostic 
support at the same time.  In most cases, the credit will cover 
all or at least most of the diagnostic investigation expenses 
for any of your routine morbidity and mortality investigations 
such as scours, pneumonia, CNS, or sudden death syndromes.   
We look forward to receiving fresh tonsils with your 
submissions and dead pigs submitted to the ADRDL.  The 
program will continue until December 31, 2007 or until funds 
are depleted.   
 Questions:  Call Dr. David Zeman at 605-688-5172 or 
email at David.Zeman@sdstate.edu
Holiday hours: 
September 3 – Labor Day 
October 8 – Native American Day 
November 12 – Veteran’s Day Observance 
 
 
Biopsy Service Changes at the 
ADRDL – Effective July 1, 2007 
 
 
 
 As part of our ongoing efforts to optimize diagnostic 
services at the ADRDL, we have instituted some changes to 
the Biopsy Service which will take effect on July 1. 
 The most important change is that lab schedules have 
been modified to ensure that a written diagnostic report 
will be faxed to the submitter within 24 hours of our 
receipt of the sample.  This report will include a 
morphologic diagnosis, or at least our initial impression of 
the lesion pending additional stains, and additional 
interpretation as indicated.  After the case is finalized, we are 
also available for phone consultation during regular business 
hours at no additional charge. 
 Another change is that a team of veterinary pathologists 
will rotate through the service, giving a high priority to 
expertise and shortened turn-around time.  Each case will be 
assigned to one team member, with challenging cases 
reviewed by all.  Team members are Dr. David Zeman, Dr. 
Tanya Graham, and Dr. David Knudsen. 
 David Zeman DVM, PhD, DACVP is a veterinary 
graduate of Oklahoma State University and PhD graduate of 
Louisiana State University, where he also completed his 
veterinary pathology residency.  He joined the ADRDL in 
1986, and is now laboratory director.  He was designated 
South Dakota veterinarian of the year in 2003 by the 
SDVMA, and laboratory diagnostician of the year in 2006 by 
the American Association of Veterinary Laboratory 
Diagnosticians (AAVLD).  He particularly enjoys infectious 
disease investigations and tumor biopsies. 
 Tanya Graham DVM, DACVP graduated from 
Oklahoma State University in 1994, then completed her 
residency in veterinary pathology at Texas A&M and then 
joined the pathology faculty at OSU.  She then worked as a 
diagnostic pathologist at the University of Pennsylvania for 
two years, and moved to the ADRDL in 2000.  She is 
associate director of the laboratory, and section head of 
Histopathology and Immunohistochemistry.  Currently, her 
interests beyond routine diagnostic pathology include avian 
pathology and regulatory diagnostic medicine. 
 David Knudsen DVM, MS, DACLAM is a 1982 
graduate of Colorado State University and was in mixed 
animal practice for three years before completing residencies 
in veterinary pathology and laboratory animal medicine at 
University of Missouri – Columbia.  After five years on staff 
at University of California – Davis, he was a private 
consultant in veterinary and comparative pathology for 
pharmaceutical and biotechnology companies before joining 
the ADRDL in 2002 as a diagnostic pathologist and section 
head for Clinical Pathology. 
 As in the past, a typical biopsy case accession includes 
processing and examination of up to 3 masses or samples 
from the same patient, up to 2 special stains as needed, 
written report plus phone consultation as needed, and return 
of the shipping container with fresh formalin, for a single 
case charge of $20 plus a $8 case generation fee.  There is no 
additional charge for decalcification, but an additional day for 
processing is generally required.  Biopsy shipping containers, 
which include a small jar of formalin and a slide mailer for 
cytologic samples, are available for a nominal initial fee. 
  
 
 
Listing of Pharmacies Offering 
Compounding Services for 
Veterinarians – April 2007 
Compiled by Regg Neiger, DVM PhD 
 
Animal Pharmacy  
66 West Avenue 
Canandaigua, NY 14424  
Phone: (800) 663-5261 
Local Phone: (585) 394-4930 
Fax: (585) 396-7264 
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Island Pharmacy Services, Inc., 
P.O. Box 1412 
Woodruff, WI 54568 
Phone: (800) 328-7060 
Fax: (715) 358-7021 
 
Pet Health Pharmacy, Inc.
12012 N. 111th Avenue  
Youngtown, AZ  85363  
Phone: (800) 742-0516
Local Phone: (623) 214-2791
Fax: (866) 373-0030
 
Pine Pharmacy   
1806 Pine Ave. 
Niagara Falls, NY 
Phone: (800) 355-1112 
Local Phone: (716) 282-1112 
Fax: (716) 282-0654 
  
Specialty Pharmacy Services, Inc 
800 E. Melbourne Ave. 
Melbourne, FL 32901 
Phone: (800) 499-7517 
Local Phone: (321) 953-2004  
Fax: (800) 784-3128  
Local Fax: (321) 953-2808  
 
Pine Pharmacy
5110 Main Street 
Williamsville, NY 
Local Phone: (716) 332-2288 
Fax: (716) 332-2287 
 
Shiner Family Pharmacy 
Carolyn Hilscher, Pharmacist/Owner 
P.O. Box 666  
408 N Avenue B 
Shiner, TX 77984  
Phone: (361) 594-2394 
 
Valley Drug and Compounding, Inc. 
16928 Ventura Blvd. 
Encino, CA 91316 
Phone: (877) 482-6231 
Local Phone: (818) 788-0635 
Fax: (818) 386-2688 
 
Red Cross Drug  
Box 2090 
Blanchard, OK  73010 
Phone: (800) 759-6963 
Local Phone: (405) 485-9311 
Fax: (405) 485-9312 
 
 
 
 
Research News - SDSU Veterinary Science Department 
 
CIDRV Research Looks at 
New HIV Drug 
 
 Researchers with the SDSU Center for Infectious 
Disease Research and Vaccinology (CIDRV) have won a 
major grant to study a new drug for treating HIV.  
 The National Institutes of Health has awarded $389,000 
to help SDSU scientists research the mechanism of action of 
a drug called bevirimat. A company called Panacos 
Pharmaceuticals Inc. makes the drug.  
 HIV, or human immunodeficiency virus, is a virus that 
causes acquired immunodeficiency syndrome, or AIDS, in 
humans. The immune system begins to fail in patients with 
AIDS, leaving them vulnerable to life-threatening infections. 
The Joint United Nations Programme on HIV/AIDS and the 
World Health Organization estimated that about 39.5 million 
people were living with AIDS at the end of 2006.  
 Principal investigator Feng Li, an associate professor 
with the CIDRV, said there are already three classes of drugs 
being used to treat HIV. Li and his co-investigator, SDSU 
assistant professor Philip Hardwidge, will study a compound 
that is the first in a new class of anti-HIV drugs called 
"maturation inhibitors."  Li said the drug interferes with virus 
particles called "virions" by not allowing the core of the 
virion to assume its mature conical shape.  
 Some researchers say virions can be compared to 
spacecraft in that they transport the genome of the virus from 
cell to cell and protect it in inhospitable environments. The 
new drug attacks HIV by disabling the virions -- it leaves 
them too immature and imperfectly formed to infect another 
host cell, and so the infection dies.  Importantly, Li said, the 
drug may help deal with the issue of drug resistance, the 
leading reason that treatments fail for HIV patients.  
 "We do have the situation where, whenever people get 
infected with HIV, that transmitted HIV strain likely already 
has developed resistance to approved drugs. The new 
inhibitor we are working on could really provide a new 
option for treatment in overcoming resistance," Li said. "This 
inhibitor is different from all the other approved drugs."  
 Hardwidge said the goal of the two-year SDSU study is 
to characterize as precisely as possible what the drug does 
and also to examine viral resistance as it relates to the drug.  
 "We have a novel compound, but at a molecular level, 
how this compound functions is not absolutely clear yet. If 
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we understand that better, we may be able to improve the 
efficacy of the drug, we may be able to modify it so that HIV 
is less prone to evolve resistance against it," Hardwidge said. 
"With all of these compounds it's crucial to understand 
precisely how they're acting in order to make them the best 
drugs they can be."  
 Li said unlike other drugs, bevirimat does not attack the 
HIV viral enzymes, which may undergo modification readily 
as new strains of the virus develop. Instead, it will attack a 
part of the virus structure protein that is highly conserved 
among different viral strains.  
 That approach gives doctors a new tool to treat drug-
resistant strains of HIV, and it also suggests the new 
compound may remain effective longer in the fight against 
HIV.  
 David Zeman, head of SDSU's Department of Veterinary 
Science, said the new grant is one example of how the 
governor's 2010 Centers of Excellence are beginning to 
produce results for South Dakota. Both Feng Li and Philip 
Hardwidge were recruited about two years ago to fill 
positions in the Center for Infectious Disease Research and 
Vaccinology. Both scientists maintain positions in both the 
SDSU Department of Veterinary Science and the SDSU 
Department of Biology/Microbiology.  
 The center fosters research leading to the development of 
novel therapeutic and diagnostic technologies and products 
for infectious diseases in humans and domestic animals.  
 Hardwidge added that the project illustrates one way that 
SDSU is looking beyond its borders to address major issues 
important to science.  
 "We're pleased with the federal funding for this project 
and we appreciate SDSU's support for basic biomedical 
research," Hardwidge said.  
 
Sources: SDSU AgBio Communications, Yankton Press and 
Dakotan 
 
 
Research Spotlight:  
Dr. Ying Fang 
 
 Dr. Ying 
Fang joined the 
faculty of the 
SDSU Veterinary 
Science 
Department and 
the Center for 
Infectious 
Disease Research 
and Vaccinology 
in 2005.  She 
holds a 
bachelor’s degree 
in Biology, 
masters degrees in Entomology and Microbiology, and a PhD 
in Veterinary Microbiology from SDSU.   
 Dr. Fang’s research has focused on the molecular 
characterization of porcine reproductive and respiratory 
syndrome virus (PRRSV) and applying that knowledge in the 
development and evaluation of vaccines and diagnostic 
assays for PRRSV.  The laboratory has successfully 
constructed a full-length cDNA (complementary DNA) 
infectious clone of European-like Type 1 PRRSV that 
recently emerged in the US.  Current efforts are directed 
towards the use of this reverse genetics system to study 
PRRSV pathogenesis and develop the next generation of 
genetically engineered PRRSV vaccines.   
 As a member of the SDSU Hybridoma Facility, she is 
directing the establishment of a panel of monoclonal 
antibodies against PRRSV non-structural proteins.  A 
collaborative project also involves developing monoclonal 
antibodies against Severe Acute Respiratory Syndrome 
(SARS-CoV) nucleocapsid protein, and the study of the basic 
mechanism of nucleocapsid protein function in the 
pathogenesis of SARS.    
 Dr. Fang’s current projects include:  
 1.  Genetic marker development in the Nsp2 region of 
a European-like PRRSV: Implication for future 
recombinant marker vaccine development.  PRRS 
continues to plague the pork industry worldwide.  To control 
this disease, there is a great need for new generations of 
PRRS vaccines.  One of the key steps in development of 
these new vaccines would be to include markers for 
diagnostic differentiation of vaccinated animals from those 
naturally infected with wild-type virus.  Such vaccines would 
greatly benefit PRRSV elimination, since it would be 
possible to assess the effectiveness of MLV vaccines.  In this 
project, a full-length cDNA infectious clone of a European-
like PRRSV isolate was constructed as a viral backbone.  
Then a marker was inserted into the unique deletion site of 
the Nsp2 region of the infectious clone as a means to identify 
vaccinated animals using routine serology. In the third step, 
conserved epitopes in the Nsp2 region were deleted so that 
the immune response to a wild-type virus could be detected in 
vaccinated pigs.  
 2.  In vivo evaluation of genetic markers in the Nsp2 
region of PRRSV: Implications for future recombinant 
marker vaccine development.  Two Nsp2 mutant viruses 
have recently been constructed.  Previous work resulted in the 
development of Nsp2 epitope-based differential ELISA 
assays.  The goal of this study is to observe how these Nsp2 
marker viruses behave in the live animal, and to study the 
potential of using the Nsp2-specific ELISAs to identify and 
differentiate vaccinated animals from naturally infected 
animals.  
 3.  Accurate ELISA test development for PRRSV 
serology: Evaluation of cysteine protease domains of Nsp2 
as potential diagnostic targets.  The overall goal of this 
study is to characterize the PRRSV cysteine protease (CP) 
domain and the conserved epitope of Nsp2 along with the 
serological response to these antigens.    
4 
Animal Health Matters 
 The cysteine protease domain (CP) of PRRSV Nsp2 was 
evaluated as a potential new antigen for sensitive, specific 
and differential diagnostic ELISA tests. Antibody to the CP 
domain could be detected as early as 14 dpi, and the CP-
based ELISA detected the antibody response to diverse field 
strains.   
 4.  Production of monoclonal antibodies against the 
PRRSV non-structural proteins.  In order to produce new, 
safe, and effective vaccines and antiviral drugs against PRRS, 
a thorough understanding of the basic biology of the virus is 
needed.  Since PRRS research began, a great deal of 
knowledge has been revealed about PRRSV’s structural 
proteins, but very little is known about PRRSV’s non-
structural proteins (Nsps).  NSPs play roles in mediating 
replication and transcription of the structural proteins of the 
virus.  This makes them attractive targets for the development 
of antiviral drugs. One of the key reagents to study protein 
structure-function and design antiviral intervention strategies 
is the monoclonal antibody (mAb).  Since the first 
development of mAbs thirty years ago, thousands of 
bioscience researchers worldwide rely on them to understand 
the structures, functions, and interactions of complex 
biomolecules.  MAbs also contribute tremendously to in vitro 
diagnostic tests and in vivo therapeutic uses in clinical 
medicine.  Previous work has built up a large panel of mAbs 
against PRRSV structural proteins, but no mAbs have been 
made against PRRSV Nsps.  Therefore, the aim of this work 
is generating a full panel of mAbs against all Nsps of Type 1 
and Type 2 PRRSV. This project will provide basic key 
reagents for study of the fundamental biology of PRRSV 
Nsps. The proteins and mAbs produced will be good 
candidates for future development of diagnostic assays. 
 5.  The Role of PRRSV Nonstructural Protein 2 in 
Viral Replication.  This is another study that looks at non-
structural proteins (Nsps) in PRRSV.  As previously 
mentioned, NSPs play roles in viral replication.  In particular, 
NSP2 has been shown to encode a putative cysteine protease, 
and in cell culture, it’s been shown that a cysteine protease 
inhibitor can block viral replication.  In addition, Nsp2 is a 
very immunogenic protein that induces an earlier immune 
response than that of PRRSV structural proteins, suggesting 
that Nsp2 may be involved in the modulation of host 
immunity.  This makes it attractive for development of 
antiviral drugs and vaccines.  This study will focus on 
elucidating the basic properties of Nsp2 in viral replication.  
From this research, a cell-free model system for the study of 
PRRSV Nsps will be created, which can be used for high 
throughput screening of anti-PRRSV drugs.  Better 
characterization of Nsp2 will allow the design and 
development of antiviral drugs, which directly target the virus 
and do not depend on the host immunity.  These would be 
extremely valuable as a means to protect certain genetic 
breeding herds and seed stock herds, such as boar studs. In 
addition, altering Nsp2 function in PRRS viruses may be a 
means for production of attenuated vaccine viruses.    
6.  The role of PRRSV non-structural protein 1 and 
2 in host immunity. The overall goal of this project is to 
understand the basic functions of PRRSV Nsp1 and Nsp2 in 
viral pathogenesis and host immunity. PRRSV infection 
typically induces a rapid, robust host humoral antibody 
response that is comprised predominantly of non-neutralizing 
antibodies. In contrast, anti-viral innate and cell mediate 
immune responses initially remain at a fairly low level. When 
anti-PRRSV neutralizing antibodies do appear, the response 
is slow and titers remain low. Many pathogens, in order to 
evade the immune system, will initially present non-
protective but immunodominant epitopes to the host immune 
system, which decoy or dysregulate the ability of the immune 
system to focus on more protective targets, and subsequently, 
suppress a more protective immune response, resulting in 
semiprotective immunity.   
Recent studies from Dr. Fang’s laboratory revealed that 
swine mount an immediate non-neutralizing antibody 
response to Nsp1 and Nsp2. The antibody response to Nsp1 
and Nsp2 is greater than that to any other PRRSV protein, 
and lasts more than 120 days, which indicates the 
immunodominant nature of these proteins. This strong, 
immediate non-neutralizing humoral response induced by 
Nsp1 and Nsp2 suggests that these proteins may be involved 
in modulation of the host immune system. Therefore, in this 
proposed study, it is hypothesized that PRRSV Nsp1 and 
Nsp2 function as immune modulators to decoy the ability of 
the immune system to focus on more protective targets. This 
study will provide basic knowledge for future development of 
more effective and broadly protective second-generation 
PRRSV vaccines.   
 
 
 
 
Extension News - SDSU ADRDL 
 
National Animal Health 
Monitoring System (NAHMS) to 
Study Beef Industry in 2007-08 
 
 The U.S. Department of Agriculture’s (USDA) NAHMS 
conducts national studies on the health and management of 
the U.S. livestock, poultry, and aquaculture populations.  
These studies are designed to meet the information needs of 
the industries and other stakeholders – as identified by people 
working with these industries. 
 In 1993, NAHMS conducted the Cow/Calf Health and 
Productivity Audit (CHAPA).  CHAPA provided baseline 
information on U.S. beef cattle inventories, health and 
management practices, forage nutrient content, and animal 
5 
Animal Health Matters 
selenium deficiency status.  The Beef ’97 study built on the 
results of CHAPA.  Objectives of the Beef ’97 study included 
describing trends in health issues affecting the U.S. beef herd 
and acquiring national prevalence estimates of 
Mycobacterium paratuberculosis (Johne’s disease) exposure 
and infections with bovine leukosis virus. 
 
NAHMS Beef 2007-08 Study 
 The NAHMS Beef 2007-08 Study will continue to 
address the priority issues of the U.S. beef cattle industry and 
other stakeholders.  Twenty-four States will participate in 
Beef 2007-08.  These states represent 79.4 percent of U.S. 
beef herds and 87.8 percent of U.S. beef cows.  The Beef 
2007-08 Study will: 
• Describe trends in beef cow-calf health and 
management practices, 
• Evaluate management factors related to beef quality 
assurance, 
• Describe record-keeping practices on cow-calf 
operations, 
• Determine producer awareness of bovine viral 
diarrhea (BVD) virus and management practices 
used for BVD control, 
• Describe current biosecurity practices and producer 
motivation for implementing or not implementing 
biosecurity practices and, 
• Determine the prevalence and antimicrobial 
resistance patterns of potential food-safety 
pathogens. 
 
 By gathering reliable and valuable information on the 
U.S. beef cattle industry, the Beef 2007-08 Study will help to 
• Educate the producers and practitioners of tomorrow 
• Help policymakers and industry make informed 
decisions, 
• Measure the impact of disease, 
• Evaluate the potential impact of diseases affecting 
beef cattle and/or human health, 
• Assist researchers and private enterprise to identify 
and focus on vital issues related to beef cattle health 
and productivity, and 
• Conduct economic analyses of the health and 
production of the U.S. beef industry. 
 
 Participation in all NAHMS studies is voluntary.  
Randomly selected producers will be contacted by 
representatives from USDA’s National Agricultural Statistics 
Service from October through November, 2007.  An on-site 
questionnaire will be administered, and eligible producers 
will be asked to participate in the second phase of the study.  
Producers that choose to continue in the study will be visited 
by veterinary medical officers (VMOs) and/or animal health 
technicians (AHTs) who will administer questionnaires and 
collect biological samples from January through March, 
2008.  VMOs and/or AHTs will make a second contact from 
July through August, 2008. 
 
Testing Options 
 Results from tests on biological samples will be provided 
to participating producers at the conclusion of the study. 
BVD Virus 
 Goal:  Estimate the percentage of calves persistently 
infected with BVD virus by testing ear notch samples.  The 
study will also help to identify factors associated with herds 
having persistently infected calves. 
Food-Safety Pathogens 
 Goal:  Estimate the prevalence of specific food-safety 
pathogens such as Salmonella and E. coli O157 via testing of 
fecal samples. 
Confidentiality 
 Because NAHMS’ studies rely on voluntary 
participation, APHIS protects the privacy of every 
participant.  Only those collecting the data know the identity 
of the respondent.  No name or address is ever recorded in 
any APHIS database.  No data will be reported on any 
individual or in a manner that would allow the identification 
of an individual. 
 
 
Pieces and Parts 
 
• Extension Publication Spotlight: 
1. Raising Cattle “Naturally”: The Significance of 
Animal Health (ExEx 11020).  “Naturally raised” 
cattle programs generally prohibit the use of 
antibiotics, ionophores, and growth promotants.  
This publication outlines some of the more 
common health ailments encountered in raising 
cattle for the natural market, along with 
management recommendations to minimize these 
problems when the usual medications used for 
prevention or treatment may not be available to be 
used.  
2. How to Capture High Calf Prices (ExEx 5055).  
Producers in South Dakota market a high 
proportion of the state’s calf crop shortly after 
weaning. Generally, the largest volume of sales 
occurs during October and November with the 
calves commonly weighing 500–600 lb. This 
publication provides suggestions for producers 
who will be selling calves on how to capture the 
relatively high prices currently available. 
3. Livestock Risk Protection:  Insuring Calves (ExEx 
5058).  Historically high cash prices for calves, 
general price volatility, and concern that prices 
could move lower may lead producers to insure 
calf prices. Livestock Risk Protection (LRP) is an 
insurance program that covers a single peril: lower 
prices.  This publication explains how LRP works 
and outlines considerations for its use.   
 
 These publications, among many others, are 
available for free at:  http://agbiopubs.sdstate.edu.  
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• Dr. Young  Named Research Coordinator for 
Veterinary Science Department.  Dr. Alan Young 
has been named Research Coordinator for the SDSU 
Department of Veterinary Science.  In making the 
announcement, Dr. David Zeman, Veterinary Science 
Department Head, said, “Dr. Young is an excellent 
team player and a natural leader, who brings forth 
positive constructive ideas to an issue.  I look forward 
to working with him and all of the department 
researchers as we grow our research program to 
maximize service to our stakeholders.”  The VSD 
Research Coordinator's role is to work closely with the 
department head and faculty on management and 
strategic issues relative to the department’s research 
program.  In this role, Dr. Young replaces Dr. David 
Francis, who will focus on his responsibilities with the 
Center for Infectious Disease Research and 
Vaccinology.   
 
 
 
Student News - SDSU Veterinary Science Department 
 
SDSU Pre-Veterinary Students 
Accepted to Veterinary Schools 
 
 Four South Dakota State University pre-veterinary 
students have been accepted to veterinary schools for Fall 
2007: 
 
 Christine Ferderer, Baltic, SD – Kansas State University 
 Nathan Runke, Willmar, MN – University of Minnesota 
 Loni Schumacher, Eureka, SD – Oklahoma State 
University 
 Kim Wellendorf, Ida Grove, IA – Iowa State University 
 
 Congratulations and good luck to these students as they 
embark upon their professional education.   
 
 
Calendar of Events       
 
August 12-15, 2007 
South Dakota Veterinary Medical Association Annual 
Meeting 
Ramkota Inn, Sioux Falls, SD 
Large and small animal sessions: Future of the ethanol 
industry/use of co-products; drug use and the VCPR in 
dairies and beef herds; latest on Johne’s disease; food animal 
diagnostics; companion animal emergency care, orthopedics; 
SDSU case reports, much more. 
605-688-6649 or www.sdvetmed.org 
 
August 1-3, 2007 
North Dakota Veterinary Medical Association Annual 
Meeting 
Doublewood Inn, Bismarck, ND 
http://www.ndvma.com
 
August 2-4, 2007 
Academy of Veterinary Consultants Summer Meeting 
Embassy Suites Hotel, Kansas City, MO 
http://www.avc-beef.org/
 
August 16, 2007 
George A. Young Swine Health and Management 
Conference 
Marina Inn, South Sioux City, NE.  
http://georgeyoungswineconference.unl.edu/
 
September 13-14, 2007 
Iowa Veterinary Medical Association Annual Meeting 
Scheman Center, Ames, IA 
http://www.iowavma.org/
 
September 15-18, 2007 
Allen D. Leman Swine Conference 
RiverCentre, St. Paul, Minnesota 
http://www.cvm.umn.edu/outreach
 
September 15-18, 2007 
Central Veterinary Conference 
Bartle Hall, Kansas City, MO 
http://www.thecvc.com
 
September 20-22, 2007 
American Association of Bovine Practitioners 
Vancouver Convention & Exhibition Centre, Vancouver, 
BC 
http://www.aabp.org/meeting/default.asp
 
 
 
 
Printed by the Veterinary Science Department, South Dakota State 
University, David Zeman, Head/Director, VSD/ADRDL.  
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 The SDSU Veterinary Science Department conducts 
research, teaching, professional service, and extension service 
to South Dakota and the surrounding region.  Entities within the 
department include the South Dakota Animal Disease Research 
and Diagnostic Laboratory, the Olson Biochemistry Laboratory, 
and the Center for Infectious Disease Research and 
Vaccinology.   
  The South Dakota Animal Disease Research and 
Diagnostic Laboratory is a full-service, all-species diagnostic 
laboratory accredited by the American Association of Veterinary 
Laboratory Diagnosticians (AAVLD).  The AAVLD accreditation 
program complies with international expectations for quality 
diagnostic services under the guidance of the World Organization 
for Animal Health (the OIE).  The ADRDL collaborates with the 
USDA National Veterinary Services Laboratory on many federal 
disease monitor and eradication programs and is a member of 
the National Animal Health Laboratory Network.  For information 
regarding the laboratory’s Quality System, contact Rajesh 
Parmar – ADRDL Quality Manager, at 605 688 4309.
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